Amanta Healthcare Stock Screener | Share Price & Fundamental Analysis
AMANTA
Pharmaceuticals
Share Price NSE
₹100.38
▲
0.88 (0.88%)
Share Price BSE
₹101.50
▲
1.55 (1.55%)
Track Amanta Healthcare share price live with TickJournal's free stock screener.
Analyze Amanta Healthcare share price history trends and compare 52-week high low
levels.
Calculate AMANTA stock fair value using fundamental analysis and view live share price charts.
Determine Amanta Healthcare share intrinsic value and compare it with current AMANTA share price.
Record your Amanta Healthcare trades in TickJournal's free trading journal and track your portfolio performance.
Amanta Healthcare Market Cap
₹399.75 Cr.
AMANTA P/E Ratio (TTM)
26.65
EPS (TTM)
₹3.71
Dividend Yield
-
Debt to Equity
2.12
AMANTA 52 Week High
₹146.20
Amanta Healthcare 52 Week Low
₹99.07
Operating Margin
22.00%
Profit Margin
5.26%
AMANTA Revenue (TTM)
₹285.00
EBITDA
₹63.00
Net Income
₹15.00
Total Assets
₹382.00
Total Equity
₹96.00
Amanta Healthcare Share Price History - Stock Screener Chart
Screen AMANTA historical share price movements with interactive charts. Analyze price trends and patterns.
Amanta Healthcare Company Profile - Fundamental Screener
Screen Amanta Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AMANTA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE084K01015
Amanta Healthcare Balance Sheet Screener
Screen AMANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 382 | 352 | 374 | 392 | 392 | 388 |
| Current Assets | 138 | 118 | 131 | 136 | 131 | 105 |
| Fixed Assets | 217 | 228 | 232 | 240 | 242 | 244 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 170 | 184 | 214 | 214 | 262 | 285 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 96 | 66 | 63 | 72 | 7 | 29 |
| Share Capital | 29 | 27 | 27 | 37 | 27 | 27 |
| Reserves & Surplus | 68 | 40 | 36 | 36 | -20 | 2 |
Amanta Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Amanta Healthcare income statement and profit fundamentals.
Analyze AMANTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Amanta Healthcare share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
| Revenue | 285 | 276 | 282 | 263 | 227 | 172 | 187 |
| Expenses | 222 | 215 | 223 | 206 | 173 | 133 | 147 |
| EBITDA | 63 | 61 | 59 | 56 | 54 | 39 | 40 |
| Operating Profit % | 22.00% | 22.00% | 21.00% | 20.00% | 23.00% | 22.00% | 20.00% |
| Depreciation | 19 | 18 | 20 | 18 | 17 | 17 | 17 |
| Interest | 23 | 28 | 34 | 35 | 49 | 40 | 38 |
| Profit Before Tax | 22 | 15 | 5 | 3 | 62 | -18 | -15 |
| Tax | 7 | 4 | 2 | 5 | 7 | 4 | 4 |
| Net Profit | 15 | 11 | 4 | -2 | 55 | -22 | -19 |
| EPS | 5.00 | 3.71 | 1.35 | -0.79 | 20.54 | -8.14 | -7.04 |
Amanta Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen AMANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 47 | 58 | 43 | 62 | 31 | 38 |
| Investing Activities | -25 | -10 | -7 | -6 | -13 | -9 |
| Financing Activities | -24 | -46 | -42 | -50 | -18 | -37 |
| Net Cash Flow | -1 | 1 | -6 | 6 | 0 | -8 |
Amanta Healthcare Shareholding Pattern Screener
See Amanta Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Amanta Healthcare promoter holding and ownership changes for AMANTA on TickJournal.
| Item | 2025-Feb | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Sept |
|---|---|---|---|---|---|---|
| Promoter Holding | 85.52% | 63.56% | 85.60% | 63.56% | 63.56% | 85.52% |
| FII Holding | 0.00% | 2.21% | 0.00% | 1.00% | 1.10% | 0.00% |
| DII Holding | 0.00% | 12.22% | 0.00% | 11.34% | 11.24% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.00% | 20.28% | 0.00% | 17.35% | 16.91% | 0.00% |
| Other Holding | 14.48% | 1.74% | 14.40% | 6.75% | 7.19% | 14.48% |
| Shareholder Count | 200 | 30,695 | 361 | 360 | 16,181 | 192 |
Amanta Healthcare Share Dividend Screener - Share Yield Analysis
Check Amanta Healthcare dividend history with payout and yield data.
View Amanta Healthcare dividend details including ex-dates and amounts for AMANTA stock.
Amanta Healthcare Stock Index Membership
See which indices include Amanta Healthcare stock.
Check AMANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Amanta Healthcare Market Events Screener - Corporate Actions
Get Amanta Healthcare corporate actions including splits, bonuses, and buybacks.
Check Amanta Healthcare stock events that may affect AMANTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Quarterly Result Announcement | NA | -0.50% | ||
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 1.14% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.51% |
Amanta Healthcare Competitors Screener - Peer Comparison
Screen AMANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 39.09 | 54,729 | 9.71% | 10,980 | 55.50 |
| Divis Laboratories | 170,126 | 69.29 | 9,712 | 18.67% | 2,191 | 57.58 |
| Torrent Pharmaceuticals | 146,659 | 65.55 | 11,539 | 6.99% | 1,911 | 65.06 |
| Cipla | 108,904 | 24.19 | 28,410 | 7.12% | 5,291 | 47.64 |
| Dr Reddys Laboratories | 107,359 | 19.93 | 33,741 | 16.73% | 5,725 | 55.60 |
| Lupin | 105,151 | 22.74 | 22,910 | 13.74% | 3,306 | 66.87 |
| Mankind Pharma | 92,782 | 52.20 | 12,744 | 20.90% | 2,007 | 63.52 |
| Zydus Life Science | 92,745 | 18.78 | 23,511 | 18.55% | 4,615 | 55.01 |
| Aurobindo Pharma | 70,881 | 20.37 | 32,346 | 9.43% | 3,484 | 58.41 |
| Alkem Laboratories | 67,429 | 28.38 | 13,458 | 3.70% | 2,216 | 51.36 |
Amanta Healthcare Company Announcements - News Screener
Screen AMANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-05 | Open Market Purchase Of Equity Shares By Promoter | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2026-02-12 | Copy Of Newspaper Publication | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-10 | Board Meeting Outcome for Unaudited Financial Results For Q3 Of FY 2025-26 | View |
| 2026-02-10 | Unaudited Financial Results For Q3 Of FY 2025-26 | View |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-02 | Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended December 31 2025. | View |
| 2026-02-02 | Intimation Of Opening Of Special Window For Transfer And Dematerialisation Of Physical Securities. | View |
| 2026-01-10 | Appointment Of Investor Relation (IR) Agency | View |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-02 | Announcement Under Regulation 30 | View |
| 2025-12-30 | Announcement Under Regulation 30 | View |
| 2025-12-29 | Closure of Trading Window | View |
| 2025-11-29 | Change In CIN Of Company | View |